Abstract:Study Objective and Hypothesis: Macroautophagy is a process that degrades unwanted cellular components (cargo) to maintain tissue homeostasis. It operates basally but is upregulated under stressful conditions such as nutrient deprivation. Myocardial autophagy is cardioprotective, whereas its downregulation can cause cardiomyopathy. We have previously shown that the G protein-coupled estrogen receptor 1 (GPER, aka GPR30) exerts both estrogen-dependent and estrogen-independent effects on components of Ca2+ signaling in the cardiovascular system. However, if and how GPER regulates myocardial autophagy is completely unknown. Here, we tested the hypothesis that GPER promotes myocardial autophagy in an estrogen-independent fashion. Methods: Cardiomyocytes were freshly isolated from male adult C57BL/6 wildtype (WT) and GPER-/- mice. Autophagy was assessed using the autophagic flux assay. Activities of upstream regulators such as mTOR and AMPK were assessed by immunoblotting. Starvation-induced Ca2+ signal (SICS) was measured by monitoring fractional indo-1 signal before and after amino acid removal. Lysosomal pH was assessed using LysoSensor Yellow/Blue DND160. In overexpression paradigms, comparisons of SICS and lysosomal pH were made between WT and GPER-overexpressing cells in the same microscopic fields in all experiments. Results: In the absence of estrogen or a GPER agonist, basal autophagic flux was lower by 13.17 ± 0.72-fold in freshly isolated GPER-/- vs WT cardiomyocytes (p 0.05). However, basal lysosomal pH was significantly higher in GPER-/- cardiomyocytes, with lysosensor ratio of 1.41 ± 0.11 vs 1.21 ± 0.12 in WT cells (n = 64; p < 0.0001), consistent with the reduction in autophagic flux. There was no significant difference in basal cytoplasmic Ca2+ levels between WT and GPER-/- cardiomyocytes (n = 53, p = 0.31). However, SICS was larger in WT (SICS AUC = 441 ± 94) than in GPER-/- (SICS AUC = 177 ± 49) cardiomyocytes (n = 25, p< 0.05). In the absence of estrogen or a GPER agonist, overexpression of ECFP-tagged GPER in HEK293 cells suppressed SICS (SICS AUC = 4.73 ± 4.27 vs 18.05 ± 7.41 in WT cells, n = 27, p < 0.0001). Lysosomal pH is significantly lower in GPER-overexpressing cells compared to non-transfected cells in both fed condition and following 30 s, 1 min, 2 min and 5 min of amino acid starvation (n = 20-26, p < 0.0001). Truncation of the PDZ-binding motif in GPER did not affect the inhibition of SICS or promotion of lysosomal acidification that are caused by expression of full-length GPER. Conclusion: These results indicate that GPER produces estrogen-independent effects to influence myocardial autophagy, likely via regulating Ca2+ signaling and lysosomal acidification. The molecular mechanism whereby GPER exerts these effects remains to be elucidated. Iowa Osteopathic & Educational Research Fund #03-20-08 to Q-KT This is the full abstract presented at the American Physiology Summit 2023 meeting and is only available in HTML format. There are no additional versions or additional content available for this abstract. Physiology was not involved in the peer review process.

Activation of G Protein-Coupled Estrogen Receptor 1 Induces Coronary Artery Relaxation Via Epac/Rap1-mediated Inhibition of RhoA/Rho Kinase Pathway in Parallel with PKA.

Activation of G protein‐coupled estrogen receptor 1 (GPER) induced coronary vasodilation by activation of MLCP via cAMP/PKA pathway

GPER inhibits diabetes-mediated RhoA activation to prevent vascular endothelial dysfunction.

GPER Acts Through the cAMP/Epac/JNK/AP-1 Pathway to Induce Transcription of Alpha 2C Adrenoceptor in Human Microvascular Smooth Muscle Cells

Activation of G Protein-Coupled Estrogen Receptor (GPER) Negatively Modulates Cardiac Excitation–Contraction Coupling (ECC) through the PI3K/NOS/NO Pathway

Receptor for Advanced Glycation End Products Involved in Circulating Endothelial Cells Release from Human Coronary Endothelial Cells Induced by C-reactive Protein

Protein Kinase G Regulates the Basal Tension and Plays a Major Role in Nitrovasodilator-Induced Relaxation of Porcine Coronary Veins.

GPER mediates estrogen cardioprotection against epinephrine-induced stress

Role of GPER in estrogen-dependent nitric oxide formation and vasodilation

Estrogen-independent regulation of myocardial autophagy by the G protein-coupled estrogen receptor 1

Nitric oxide and protein kinase G act on TRPC1 to inhibit 11,12-EET-induced vascular relaxation

Abstract 323: G-Protein Coupled Estrogen Receptor 1 Activation Protects the Heart Against Ischemia/Reperfusion Injury by Inhibiting the Mptp Opening Via PKC/ERK/GSK-3? Pathway

The GPER Agonist G‐1 Induces Mitotic Arrest and Apoptosis in Human Vascular Smooth Muscle Cells Independent of GPER

Activation of G Protein-Coupled Estrogen Receptor 1 (GPER-1) Ameliorates Blood-Brain Barrier Permeability after Global Cerebral Ischemia in Ovariectomized Rats.

G Protein-Coupled Estrogen Receptor 1 Mediates Acute Estrogen-Induced Cardioprotection via MEK/ERK/GSK-3β Pathway after Ischemia/Reperfusion

Anti-Inflammatory Actions of G-Protein-Coupled Estrogen Receptor 1 (GPER) and Brain-Derived Estrogen Following Cerebral Ischemia in Ovariectomized Rats

Abstract Mo139: PDE1, 3 and 4 Inhibition and GPCR Agonism in the Regulation of cAMP Signaling

GPR 30 Reduces Myocardial Infarct Area and Fibrosis in Female Ovariectomized Mice by Activating the PI3K/AKT Pathway

Phosphodiesterases coordinate cAMP propagation induced by two stimulatory G protein-coupled receptors in hearts

Notoginsenoside Ft1 Activates Both Glucocorticoid and Estrogen Receptors to Induce Endothelium-Dependent, Nitric Oxide-Mediated Relaxations in Rat Mesenteric Arteries.

G protein estrogen receptor as a potential therapeutic target in Raynaud's phenomenon